Market Research Logo

Global Dravet Syndrome Treatment Market 2018-2022

Global Dravet Syndrome Treatment Market 2018-2022

About Dravet Syndrome

Dravet syndrome is a rare disease and is a severe form of epilepsy that is a part of the group of diseases known as SCN1A-related seizure disorders. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.

Technavio’s analysts forecast the Global Dravet Syndrome Treatment Market to grow at a CAGR of 8.35% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the dravet syndrome treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of dravet syndrome across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, dravet syndrome treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Biocodex
  • Epygenix Therapeutics
  • GW Pharmaceuticals
  • OPKO Health
  • Zogenix
Market driver
  • Rising number of strategic alliances
  • For a full, detailed list, view our report
Market challenge
  • Low awareness
  • For a full, detailed list, view our report
Market trend
  • Increased use of new generation drugs
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CNS disorders drugs market segmentation
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global Dravet syndrome treatment market - Market size and forecast 2017-2022 ($ mn)
      • Table Global Dravet syndrome treatment market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Drugs under development
      • Table Pipeline landscape by development phase
      • Table Molecules in the pipeline
  • Market segmentation by product
    • Segmentation by product
      • Table Global Dravet syndrome treatment market by product - Market share 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • SGD - Market size and forecast 2017-2022
      • Table SGD - Market size and forecast 2017-2022 ($ mn)
      • Table SGD - Year-over-year growth 2018-2022 (%)
    • TGD - Market size and forecast 2017-2022
      • Table TGD - Market size and forecast 2017-2022 ($ mn)
      • Table TGD - Year-over-year growth 2018-2022 (%)
    • FGD - Market size and forecast 2017-2022
      • Table FGD - Market size and forecast 2017-2022 ($ mn)
      • Table FGD - Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global Dravet syndrome treatment market - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increased use of new generation drugs
    • Advances in biomedical sciences
    • Strong pipeline
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Biocodex
      • Table Biocodex – Overview
      • Table Biocodex - Organizational developments
      • Table Biocodex - Key offerings
      • Table Biocodex - Key customers
    • Epygenix Therapeutics
      • Table Epygenix Therapeutics – Overview
      • Table Epygenix Therapeutics - Organizational developments
      • Table Epygenix Therapeutics - Key offerings
      • Table Epygenix Therapeutics - Key customers
    • GW Pharmaceuticals
      • Table GW Pharmaceuticals – Overview
      • Table GW Pharmaceuticals - Business segments
      • Table GW Pharmaceuticals - Organizational developments
      • Table GW Pharmaceuticals - Geographic focus
      • Table GW Pharmaceuticals - Segment focus
      • Table GW Pharmaceuticals - Key offerings
      • Table GW Pharmaceuticals - Key customers
    • OPKO Health
      • Table OPKO Health – Overview
      • Table OPKO Health - Business segments
      • Table OPKO Health - Organizational developments
      • Table OPKO Health - Geographic focus
      • Table OPKO Health - Segment focus
      • Table OPKO Health - Key offerings
      • Table OPKO Health - Key customers
    • Zogenix
      • Table Zogenix – Overview
      • Table Zogenix - Business segments
      • Table Zogenix - Organizational developments
      • Table Zogenix - Geographic focus
      • Table Zogenix - Segment focus
      • Table Zogenix - Key offerings
      • Table Zogenix - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report